Study Objective: The purpose of this study was to determine the proportion of patients achieving recommended target lipid levels in a group of community-dwelling patients who were prescribed HMG-CoA Reductase inhibitors (“statins”). Principal Investigator: Tsuyuki RT Co-Investigator: Olson K Status: Completed Abstract: 1. Olson KL, Tsuyuki RT. A Community-based, Cross-sectional Evaluation of Patients; Achievement of […]
Study Objective: To determine the efficacy of a program of intervention by community pharmacists in high risk coronary heart disease (CHD) patients on lipid-risk management. Principal Investigator: Tsuyuki, R.T. Co-Investigators: Status: Completed, published (see Publications below) Editorial: Pharmacy Practice, May 2003 Publications: 1. Tsuyuki RT, Johnson JA, Teo KK, Ackman ML, Biggs R, Cave A, […]
A randomized, double blind clinical trial using the lipid lowering agent, Simvastatin, and the angiotensin converting enzyme inhibitor, Enalapril, to promote regression of coronary atherosclerosis. Contact Person: Dr. Koon K. Teo Publications: 1. Koon K Teo MB PhD, Jeffrey R Burton MD, Joseph DeAlmeida PEng, Shelley Dolezsar BSc, Patricia A Montague BSc, Vladimir Dzavik MD, […]
This study will evaluate if the use of prebiotics is effective and tolerable for prevention of relapses in ulcerative colitis as well as to determine their protective mechanisms.
Abstract as Presented at the Canadian Cardiovascular Congress October 2011 (Updated October 19, 2011) Congestive Heart Failure Outreach Program of Education (COPE): a Randomized, Controlled Study R.T. Tsuyuki, E.E. Lockwood, M.C. Shibata, S. Simpson, K.L. Olson, R. Gutierrez, M.C. Reddy, M Fradette Background Acute precipitants of heart failure (HF) often relate to poor self-care […]
ABLE cGVHD – Applied Predictive Biomarkers For Pediatric Chronic Graft-Versus-Host Disease in Late Effects of Childhood Cancer
ABLE Cisplatin Ototoxicity and Nephrotoxicity Biomarkers: a project of the Applying Biomarkers to Long-term Effects of Childhood/Adolescent Cancer Treatment Team
Vancomycin’s objective is to determine if using topical vancomycin as a prophylactic treatment during open heart surgery will reduce the incidence of sterna wound infection (SWI).
The goal of this branch of ABLE is to determine the relationship of biomarkers to risk of thrombosis events in a large cohort of Canadian survivors of childhood cancer. As well, to determine other risk factors for thrombosis in a large cohort of Canadian survivors of childhood cancer.